Macquarie Group’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.7M Buy
24,157
+6,229
+35% +$1.65M 0.05% 255
2026
Q1
$1.96M Sell
17,928
-2,700
-13% -$385K 0.01% 536
2025
Q4
$3.43M Sell
20,628
-73,942
-78% -$12.4M 0.02% 479
2025
Q3
$18.5M Buy
94,570
+26,690
+39% +$4.39M 0.02% 686
2025
Q2
$6.14M Sell
67,880
-833,557
-92% -$65.9M 0.01% 935
2025
Q1
$53.8M Buy
901,437
+895,804
+15,903% +$82.9M 0.07% 396
2024
Q4
$746 Buy
+5,633
New +$529K ﹤0.01% 1598

Other funds holding ALAB

Macquarie Group's ALAB Position: Q2 2026 in Review

Macquarie Group increased its Astera Labs (ALAB) stake by 35% in Q2 2026, buying an estimated $1.65M and bringing the position to 24,157 shares worth $11.7M. The position accounts for 0.05% of the portfolio, ranked #255.

Macquarie Group first reported a position in ALAB in Q4 2024 and has held it in 7 quarters since. The position peaked at $53.8M in Q1 2025. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Macquarie Group held 24,157 shares of Astera Labs worth $11.7M as of Q2 2026.
  • Macquarie Group bought 6,229 Astera Labs shares in Q2 2026, an estimated $1.65M.
  • Astera Labs made up 0.05% of Macquarie Group's portfolio in Q2 2026, its #255 holding.
  • Macquarie Group first reported a position in Astera Labs in Q4 2024 and has held it in 7 quarters since.
  • Macquarie Group's Astera Labs position peaked at $53.8M in Q1 2025.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Macquarie Group's 13F filing for Q2 2026, filed 14 Aug 2026.